News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No significant news items were published in the past hour.
  • No central bank statements or policy moves occurred during the hour.
  • No major corporate earnings, M&A, or credit events were reported.
  • No new geopolitical incidents or sanctions were announced in the past hour.
  • No market-moving economic data releases occurred in the hour.
  • Overall newsflow was light, leaving markets without fresh catalysts.

Latest Articles

USA Rare Earth (Nasdaq: USAR) Announces Completion of Upsized $1.55 Billion Capitalization of the U.S. Government-Backed Special Purpose Vehicle (SPV) for Serra Verde Offtake

USA Rare Earth (Nasdaq: USAR) Announces Completion of Upsized $1.55 Billion Capitalization of the U.S. Government-Backed Special Purpose Vehicle (SPV) for Serra Verde Offtake

USA Rare Earth announced the completion of capitalization of a $1.55 billion Special Purpose Vehicle backed by the U.S. Government to purchase 100% of Phase 1 production from Serra Verde, a key rare earth producer. The Department of War committed $750 million, and the Company secured a $500 million senior debt facility, underpinning the acquisition…

Biomea Fusion Announces Completion of Enrollment in COVALENT-211 Phase II Trial of Icovamenib in Insulin-Deficient Type 2 Diabetes

Biomea Fusion Announces Completion of Enrollment in COVALENT-211 Phase II Trial of Icovamenib in Insulin-Deficient Type 2 Diabetes

Biomea Fusion has completed enrollment in its COVALENT-211 Phase II trial evaluating icovamenib in insulin-deficient type 2 diabetes patients inadequately controlled on antihyperglycemic therapies. The trial enrolled 64 patients, assessing icovamenib's ability to restore beta-cell function and provide durable glycemic control, with topline results …

WRAP: Laser Counter-UAS Technology Added to WrapShield™, Expanding Into DoW, DHS and Tactical Law Enforcement Markets

WRAP: Laser Counter-UAS Technology Added to WrapShield™, Expanding Into DoW, DHS and Tactical Law Enforcement Markets

Wrap Technologies announced an expanded strategic relationship with Frenel Imaging to integrate advanced laser directed-energy counter-UAS technologies into its WrapShield platform, aiming to commercialize across U.S. and NATO markets. This move introduces mobile, scalable laser systems optimized for repeated drone engagements, addressing the evolv…

Ashland advances high-growth oral biologics delivery applications with launch of permexa™ sodium caprate

Ashland advances high-growth oral biologics delivery applications with launch of permexa™ sodium caprate

Ashland Inc. has introduced permexa™ sodium caprate, an intestinal permeation enhancer designed to support the scalable development and commercialization of oral peptide, biologic, and low-permeability drugs, including GLP-1 agonists. This innovation addresses manufacturing challenges such as formulation consistency and process robustness, and is i…

Tiziana Life Sciences Announces Poster Presentation on Phase 2a BANYAN Clinical Trial of Intranasal Foralumab at ALS Nexus 2026

Tiziana Life Sciences Announces Poster Presentation on Phase 2a BANYAN Clinical Trial of Intranasal Foralumab at ALS Nexus 2026

Tiziana Life Sciences announced a poster presentation detailing the Phase 2a BANYAN clinical trial of intranasal foralumab for ALS treatment. The trial, part of the Healey ALS MyMatch program, evaluates safety, immune biomarkers, and clinical effects of the investigational therapy, which targets the regulatory T cell pathway to modulate neuroinflam…

Mesoblast Financial Results and Corporate Update Webcast

Mesoblast Financial Results and Corporate Update Webcast

Mesoblast Limited, an innovator in allogeneic cellular therapies, will host a webcast to discuss its FY 2026 financial results and operational updates. The company, with products including the FDA-approved Ryoncil® for steroid-refractory acute graft versus host disease, continues to develop multiple therapies for inflammatory and cardiac conditions…

VERAXA Biotech and Secarna Pharmaceuticals Achieve Research Milestone in Antibody Oligonucleotide Conjugate (AOC) Alliance

VERAXA Biotech and Secarna Pharmaceuticals Achieve Research Milestone in Antibody Oligonucleotide Conjugate (AOC) Alliance

VERAXA Biotech AG and Secarna Pharmaceuticals announced promising initial results from their collaboration developing antibody oligonucleotide conjugates (AOCs), showing enhanced potency in early in vitro studies. This milestone underscores the therapeutic potential of AOCs to improve targeted treatments for autoimmune and chronic immune diseases. …

Martin Marietta Completes Combination With Lhoist North America

Martin Marietta Completes Combination With Lhoist North America

Martin Marietta Materials, Inc. has completed its acquisition of Lhoist North America, expanding its Specialties platform and positioning itself as the leading limestone producer in the U.S. The transaction strengthens Martin Marietta's asset base with high-quality reserves and broadens its exposure across key industrial end markets such as steel m…

ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors

ANI Pharmaceuticals Appoints Henry Gosebruch to Board of Directors

ANI Pharmaceuticals announces the appointment of Henry Gosebruch, an experienced biopharmaceutical executive, to its Board of Directors to strengthen corporate strategy and business development as it accelerates its transformation into a leading Rare Disease company. The company also notes a board resignation but retention in executive roles, highl…

Indian Equities Slip as FMCG, Healthcare, Consumer Durables Weigh on Close

Indian Equities Slip as FMCG, Healthcare, Consumer Durables Weigh on Close

Indian equity markets closed lower on Monday with the Nifty 50 down 0.14% and the BSE Sensex 30 off 0.22%. Losses were concentrated in Fast Moving Consumer Goods, Healthcare and Consumer Durables. Market breadth showed more decliners than advancers on both major exchanges, while the India VIX rose and key commodity and currency benchmarks moved mat…

Parsons Secures $514 Million Missile Defense Agency Contract Option

Parsons Secures $514 Million Missile Defense Agency Contract Option

Parsons Corporation has secured a $514 million, two-year contract option from the U.S. Missile Defense Agency to continue providing technical, engineering, analytical, and oversight support for the integrated Missile Defense System. This contract extension highlights Parsons' role in enhancing national missile defense capabilities against advanced …

nVent to Acquire Maverick Power

nVent to Acquire Maverick Power

nVent Electric plc is acquiring Maverick Power for $1.75 billion, with potential additional consideration up to $550 million based on performance metrics. The acquisition strengthens nVent's position in the high-growth data center infrastructure sector by adding power distribution platforms and expanding system-level solutions. The deal is expected…

PDD Holdings Announces Second Quarter 2026 Unaudited Financial Results

PDD Holdings Announces Second Quarter 2026 Unaudited Financial Results

PDD Holdings Inc. announced its unaudited financial results for Q2 2026, reporting an 8% increase in total revenues to RMB112.4 billion ($16.6 billion), driven by a 13% rise in transaction services. Operating profit increased by 8%, while net income attributable to ordinary shareholders decreased by 12% compared to the same quarter last year. Manag…

China Urges Immediate Talks as Middle East Tensions Reach 'Critical Point'

China Urges Immediate Talks as Middle East Tensions Reach 'Critical Point'

China's foreign minister called on Monday for immediate dialogue to prevent further escalation in the Middle East and Gulf region, saying de-escalation must be the priority. Speaking in Beijing during a meeting with Kuwait's foreign minister, the Chinese official said recurring cycles of conflict should be avoided and offered closer coordination wi…

Buy EXOR for Cheap Ferrari Exposure and Lingotto Optionality

Buy EXOR for Cheap Ferrari Exposure and Lingotto Optionality

EXOR (EXXRF) is trading near key technical support after a measured pullback. For investors who want concentrated Ferrari exposure plus optional upside from EXOR’s real-estate and holding-company optionality, a long trade at $82.60 offers asymmetric reward: limited downside with a clear stop and a multi-month horizon to realize a re-rating or value…

Comstock Receives $20 Million and Closes Sale of Legacy Mining Assets to Mackay Precious Metals Inc.

Comstock Receives $20 Million and Closes Sale of Legacy Mining Assets to Mackay Precious Metals Inc.

Comstock Inc. has closed the sale of its legacy mining assets for over $45 million to Mackay Precious Metals Inc., including cash and equity, as part of its strategic transformation from a hard rock mining company to a renewable metals and materials business. The transaction improves liquidity, reduces costs, and positions Comstock for growth in so…

Non-Mortgage Delinquency Growth Slows in Second Quarter, but Ontario Homeowners Remain Under Pressure

Non-Mortgage Delinquency Growth Slows in Second Quarter, but Ontario Homeowners Remain Under Pressure

Equifax Canada’s Q2 2026 report shows Canadian consumer debt increasing year-over-year, with non-mortgage delinquency rates slightly improving overall but worsening in Ontario, where mortgage holders face increased financial pressure. Credit card and auto loan balances rose seasonally, while consumer caution affects spending and borrowing behavior.…